Nov 26, 2025
Chengdu
According to a recent announcement of listed Chengdu enterprise Berry Genomics, the third-generation gene sequencer, Sequel II CNDx, developed by its subsidiary has officially received the medical device registration certificate from the National Medical Products Administration. It is worth noting that it is the world’s first third-generation gene sequencing platform approved for clinical application. This milestone marks China’s official entry into a new era of long-read and high-precision clinical gene sequencing.
Source: Chengdu Discovery
Welcome to the Salon On New Quality Productive Forces!
Major exhibitions in Shanghai this December
Exhibition of Fine Export Artifacts of Qing Dynasty Collected by Dongguan Museum
New exhibit on Mayan civilization opens in Hebei Museum
Voronezh State Symphony Orchestra of Russia — New Year's Concert